Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$4.81

Avg closing price
Price range

5 Ken Griffin Sonnet BioTherapeutics Holdings Trades

The first Sonnet BioTherapeutics Holdings trade was made in Q1 2021. Since then Ken Griffin bought shares one more times and sold shares on three occasions. The investor completely sold their stake between Q2 2022 and Q3 2022.

Avg closing price
Price range
Sold -50 shares Q3 2022
Avg closing price $3.32
Price range $1.32 - $4.35
Sold 96.2% shares (-1.27 Thousand shares) Q2 2022
Avg closing price $4.07
Price range $3.22 - $5.91
New holding (+1.32 Thousand shares) Q1 2022
Avg closing price $4.81
Price range $3.85 - $7.53
Sold -367 shares Q2 2021
Avg closing price $24.84
Price range $20.44 - $33.46
New holding (+367 shares) Q1 2021
Avg closing price $35.92
Price range $28.42 - $47.04

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!